Targeting a Key FAK-tor: the Therapeutic Potential of Combining Focal Adhesion Kinase (FAK) Inhibitors and Chemotherapy for Chemoresistant Non-Small Cell Lung Cancer.
EXPERT OPINION ON INVESTIGATIONAL DRUGS（2024）
Key words
NSCLC,focal adhesion kinase (FAK),FAK inhibitors,chemoresistance,combination therapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined